We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MCK:NYSEMcKesson Corporation Analysis

Data as of 2026-03-09 - not real-time

$942.16

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

McKesson is trading well above its short‑term support but still below its long‑term moving averages, indicating a bullish bias despite a recent bearish MACD crossover. The stock’s price is comfortably under its discounted cash‑flow fair‑value estimate, suggesting a modest upside, while the RSI hovers around the mid‑50s, reflecting neutral momentum. Revenue growth remains double‑digit and cash flow generation is strong, supporting the current dividend with a very low payout ratio. Recent market sentiment is highly positive, as reflected by an “Extreme Greed” reading on the fear‑greed index, and analyst coverage leans toward a buy recommendation.
Overall, the combination of solid fundamentals, attractive valuation relative to intrinsic value, and a defensive dividend profile makes MCK a compelling hold with upside potential, provided investors stay mindful of short‑term technical headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support but above key moving averages
  • Bearish MACD histogram indicating short‑term downside pressure
  • Stable trading volume limiting abrupt moves

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth outpacing industry peers
  • DCF fair‑value indicates modest upside
  • Low beta and defensive dividend support risk‑adjusted returns

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong cash‑flow generation and low payout ratio
  • Strategic position in healthcare distribution with secular demand
  • Undervalued relative to intrinsic value and favorable long‑term industry dynamics

Key Metrics & Analysis

Financial Health

Revenue Growth11.40%
Profit Margin1.09%
P/E Ratio27.2
ROA4.33%
P/B Ratio-89.3
Op. Cash Flow$10.5B
Free Cash Flow$9.2B
Industry P/E25.4

Technical Analysis

TrendBullish
RSI52.9
Support$894.59
Resistance$999.00
MA 20$953.47
MA 50$882.99
MA 200$783.61
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair Value$1,614.35
Target Price$995.27
Upside/Downside5.64%
GradeUndervalued
TypeBlend
Dividend Yield0.36%

Risk Assessment

Beta0.13
Volatility53.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.